Supply of Lidocaine Patches (Medical Pharmaceutical Product)

The contract pertains to the manufacturing and delivery of lidocaine transdermal patches that meet U.S. Food and Drug Administration standards for medical pharmaceutical use, specifically for distribution to Fort Campbell, Kentucky. The products must adhere strictly to Department of Defense packaging and labeling requirements, ensuring compatibility with military supply protocols and field readiness. This subcontract falls under the NAICS code 325412, indicating classification within pharmaceutical and medicinal product manufacturing, and is issued by the Defense Logistics Agency under the Department of Defense to support military medical needs. The delivery is scheduled under a specific contract award linked to SPE2DP26F8787, with performance tied to designated military locations, although exact geographic details for performance or office coordination are not provided. The contract was posted in August 2026 and represents a direct procurement initiative to secure a critical pharmaceutical supply for DoD medical operations, emphasizing compliance, quality control, and logistical alignment with defense infrastructure. No set-aside provisions or small business designations are indicated, suggesting this is a competitive or full and open acquisition under the agency’s broader medical supply chain strategy.